Firm at a glance
Pemba Capital Partners is a platform private equity firm headquartered in Sydney, NSW, and has reported raising more than $2 billion in funds, per its own website [S1].
What they buy
Pemba’s portfolio demonstrates a concentration in technology businesses, with approximately half of its disclosed investments falling into this category [S1]. The firm also maintains active positions in healthcare, business services, and financial services companies across Australia and New Zealand [S1]. Observed acquisitions span software, professional services, veterinary care, and specialized financial products, suggesting a focus on recurring revenue models in fragmented sectors [S1].
Portfolio
Technology
HRL Technology (December 2025), Ektimo (December 2025), SKUTOPIA (July 2025), Locatrix (March 2025), Satori (October 2024), ctrl:cyber (July 2024), Droppoint (December 2023), ADDA (October 2023), Oolio Group (February 2023), RxPx (September 2022), Aurizn (June 2022), Smart Loyalty (November 2017), ReadyTech (June 2016) [S1].
Healthcare
HealthCare Logic (August 2025), QVS (July 2023), Sterling Group (July 2023), Lumia Care (April 2022), Vets Central (September 2021) [S1].
Business Services
Stannards (September 2024), Sequana (September 2024), Rennie (January 2024), Outsourced (October 2022), ConnellGriffin (August 2022) [S1].
Financial Services
Bravas (June 2025), SuperConcepts (July 2023), Arteva Funding (January 2021) [S1].
Recent activity (last 24 months)
– **December 2025**: Acquisition of HRL Technology [S1]
– **December 2025**: Acquisition of Ektimo [S1]
– **August 2025**: Acquisition of HealthCare Logic [S1]
– **July 2025**: Acquisition of SKUTOPIA [S1]
– **June 2025**: Acquisition of Bravas [S1]
– **March 2025**: Acquisition of Locatrix [S1]
– **October 2024**: Acquisition of Satori [S1]
– **September 2024**: Acquisition of Stannards [S1]
– **September 2024**: Acquisition of Sequana [S1]
– **July 2024**: Acquisition of ctrl:cyber [S1]
How this firm fits a seller
Pemba’s transaction velocity, with ten acquisitions completed in the trailing 24 months, indicates an active deployment cycle [S1]. The firm’s portfolio composition suggests a preference for established businesses in technology and professional services sectors where consolidation strategies may apply. For owner-operators in Australia or New Zealand operating software, healthcare services, or specialized business services companies, Pemba represents a locally based buyer with demonstrated sector experience. The firm’s capital base of more than $2 billion in raised funds suggests capacity for platform acquisitions across multiple verticals [S1].
Sources
[S1] https://pemba.com.au (as of 2026-05-15)
Frequently asked questions
Does Pemba Capital Partners buy technology businesses?
Yes, technology represents the largest sector concentration in Pemba’s portfolio, with 13 disclosed technology investments including recent acquisitions of HRL Technology, Ektimo, SKUTOPIA, and Locatrix in 2025 [S1]. The firm has consistently acquired software and technology-enabled service businesses since at least 2016 [S1].
What companies has Pemba Capital Partners acquired recently?
Pemba’s most recent disclosed acquisitions include HRL Technology and Ektimo in December 2025, HealthCare Logic in August 2025, and SKUTOPIA in July 2025 [S1]. The firm completed ten acquisitions in the 24 months ending December 2025 [S1].
Where is Pemba Capital Partners based and how big is the firm?
Pemba Capital Partners is headquartered in Sydney, NSW, with its sole office location in Sydney [S1]. The firm has reported raising more than $2 billion in funds, per public sources as of May 2026 [S1].
Is Pemba Capital Partners still actively acquiring?
Yes, Pemba completed two acquisitions in December 2025 and ten total acquisitions in the trailing 24 months, indicating ongoing active deployment [S1]. The firm’s recent transaction pace suggests continued acquisition activity as of early 2026.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.